Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

(2016) Peter Alping et al.   ANNALS OF NEUROLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

(2016) Mike P Wattjes et al.   Multiple Sclerosis Journal

Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

(2016) Mike P Wattjes et al.   Multiple Sclerosis Journal

Increasing prevalence of multiple sclerosis in Västerbotten County of Sweden

(2015) A. Svenningsson et al.   ACTA NEUROLOGICA SCANDINAVICA

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

(2015) A. Traboulsee et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring

(2015) Anthony Traboulsee et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol

(2015) Dragan A. Stojanov et al.   EUROPEAN RADIOLOGY

Treating relapsing–remitting multiple sclerosis: therapy effects on brain atrophy

(2015) Angela Vidal-Jordana et al.   JOURNAL OF NEUROLOGY

OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol

(2015) F. Cotton et al.   JOURNAL OF NEURORADIOLOGY

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

(2015) Àlex Rovira et al.   Nature Reviews Neurology

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

(2015)   Nature Reviews Neurology

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

(2015) Robert J. McDonald et al.   RADIOLOGY

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

(2014) Tatiana Plavina et al.   ANNALS OF NEUROLOGY

A changing treatment landscape for multiple sclerosis: challenges and opportunities

(2014) F. Piehl   JOURNAL OF INTERNAL MEDICINE

MRI pattern in asymptomatic natalizumab-associated PML

(2014) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

(2014) Christian Confavreux et al.   LANCET NEUROLOGY

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

High Nationwide Incidence of Multiple Sclerosis in Sweden

(2014) Cecilia Ahlgren et al.   PLoS One

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis

(2013) Omar Khan et al.   ANNALS OF NEUROLOGY

Progressive multifocal leukoencephalopathy after natalizumab discontinuation

(2013) Andrew J. Fine et al.   ANNALS OF NEUROLOGY

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

(2013) Massimo Filippi et al.   NEUROLOGICAL SCIENCES

High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material

(2013) Tomonori Kanda et al.   RADIOLOGY

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

(2012) Henrik S. Thomsen et al.   EUROPEAN RADIOLOGY

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

(2012) Jeffrey A Cohen et al.   LANCET

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

(2012) Alasdair J Coles et al.   LANCET

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

(2012) Giancarlo Comi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic

(2012) Ebru Erbayat Altay et al.   JAMA Neurology

Incidence of Immediate Gadolinium Contrast Media Reactions

(2011) Martin R. Prince et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

High nationwide prevalence of multiple sclerosis in Sweden

(2011) C Ahlgren et al.   Multiple Sclerosis Journal

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

(2011) Paul O'Connor et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relapses in multiple sclerosis are age- and time-dependent

(2008) H Tremlett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY